Olmesartan Medoxomil in Diabetes Mellitus

Clinical trial NCT00185159 · COMPLETED

Trial details

NCT number: NCT00185159
Sponsor: Sankyo Pharma Gmbh
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2 Cardiovascular Disease Kidney Disease

Start date: 2004-10-01
Primary completion: 2009-07-01
Enrollment: 4449

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.